MARLENE A ANDERSON-REID

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health GAINESVILLE, GA NPI 1396089181

General Payments — all program years on this page

$1,698.09

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 82
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $427.38 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $427.3821

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $288.1917
2022 $444.1120
2023 $538.4124
2024 $427.3821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086273104 Bayer Healthcare Pharmaceuticals Inc. $20.27 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086364783 Bayer Healthcare Pharmaceuticals Inc. $16.27 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086775343 Novartis Pharmaceuticals Corporation $21.16 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086775359 Novartis Pharmaceuticals Corporation $24.02 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086775361 Novartis Pharmaceuticals Corporation $21.64 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089393738 Daiichi Sankyo Inc. $20.34 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104525984 AstraZeneca Pharmaceuticals LP $21.40 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104571674 AstraZeneca Pharmaceuticals LP $22.82 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115807314 GlaxoSmithKline, LLC. $19.63 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117190603 Amgen Inc. $26.39 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124034457 Vifor Pharma, Inc. $28.22 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135755853 Lilly USA, LLC $13.09 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135807563 Lilly USA, LLC $16.85 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139909765 GENZYME CORPORATION $22.88 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149940228 Travere Therapeutics, Inc. $17.71 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150695092 Aurinia Pharma U.S., Inc. $22.35 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150695094 Aurinia Pharma U.S., Inc. $18.49 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154199335 Fresenius USA Marketing, Inc. $15.88 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154199337 Fresenius USA Marketing, Inc. $17.29 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154199339 Fresenius USA Marketing, Inc. $19.75 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154199341 Fresenius USA Marketing, Inc. $20.93 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.